Bladder Cancer Research Innovation Awardees

Christopher Garris, PhD, BS

Assistant Professor, Pathology, Center for Systems Biology, Massachusetts General Hospital

Research: Overcoming immune suppressive myeloid cell barriers in bladder cancer

Read more

John Taylor, MD, MS

Professor, Urology; Co-Leader, Drug Discovery Development & Experimental Therapeutics

Research: Exploring therapeutic vulnerabilities for drug development in bladder cancer using Down Syndrome as a novel model

Read more

Tyler Curiel, MD, MPH

Gmelich Chair in Cancer Immunology Research at the Dartmouth-Hitchcock Clinic

Research: Rationally engineered IL2 for enhanced treatment of local and metastatic BC

Read more

John Sfakianos, MD

Assistant Professor, Urologic Oncology at the Icahn School of Medicine at Mount Sinai

Research: High resolution molecular imaging to elucidate the contextual mechanisms of BCG resistance in non-muscle invasive recurrent bladder cancer

Read more

2021

Weiguo Cui, PhD

Professor, Department of Pathology, Northwestern University

Research: Discovering what factors lead to T cell exhaustion and finding ways to reverse it.

Read more

2021

John K. Lee, MD, PhD
Assistant Professor in the Human Biology Division at the Fred Hutchinson Cancer Research Center

Research: Inform new and effective treatment strategies for those suffering from variant bladder cancers.

Read more

Jeffrey Ravetch, MD, PhD
Professor, Rockefeller University

Research: “Intravesical delivery of FC-enhanced CD40 against antibody for the treatment of bladder cancer.”

Read more

Philip Beachy, PhD
Professor, Stanford University School of Medicine

Research: “Transdifferentiation of fibroblasts to urothelial progenitors for definitive urothelial replacement therapy in non-muscle invasive bladder cancer.”

Read more

Michael M. Shen, PhD
Professor, Columbia University Irving Cancer Center

Research: “Modeling bladder cancer metastasis using human patient-derived tumor organoids.”

Read more

Seth Lerner, MD, FACS
Chair of Urologic Oncology, Baylor College of Medicine

Research: “Proteogenomic characterization of MIBC to identify mechanisms of resistance and targets for therapy.”

Read more

David McConkey, PhD
Director, Johns Hopkins Greenberg Bladder Cancer Institute
The JPB Foundation Bladder Cancer Research Innovations Award

Research: “Targeting FGFR3 in muscle-invasive bladder cancer.”

Cory Abate-Shen, PhD
Professor of Urological Oncology, Columbia University Medical Center
Associate Director of Translational Research, Herbert Irving Comprehensive Cancer Center

James Family Foundation and Partner Fund Management Bladder Cancer Research Innovations Award

Research: “Epigenetic regulation of bladder cancer progression.”

William Kim, MD
Associate Professor, University of North Carolina at Chapel Hill
The JPB Foundation Bladder Cancer Research Innovations Award

Research: “Immune Characterization of High-Grade Bladder Cancer.”